Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,053.11
+21.591.06%
Number of Gainers:775
Number of Losers:237
Number of Flat:12
PE:- -
High:2,056.64
Open:2,031.77
Low:2,031.77
Close:2,031.52
Volume:2.60B
Turnover:328.97B
Market Cap:95.66T
Float Cap:89.45T

Loading ...

PPI Public Property Invest Tightens Capital Structure with SEK 23m Share Buy-Back

TIPRANKS
·
Sep 08

Goldman Sachs Remains a Hold on TeamViewer AG (TMV)

TIPRANKS
·
Sep 08

UBS Group AG (UBS) Gets a Buy from J.P. Morgan

TIPRANKS
·
Sep 08

ING GROEP (0RIC) Gets a Buy from J.P. Morgan

TIPRANKS
·
Sep 08

Transgene Expands ProBioGen Partnership with New AGE1.CR.pIX Cell Line License

Reuters
·
Sep 08

Gold Price Consolidates in Narrow Range as Rate Hike Expectations Shift

Deep News
·
Sep 08

FTSE 100 Live: Stocks to open flat as oil rises on new Hormuz sanctions

cityam
·
Sep 08

TOBESOFT Sees Accounting-Book Injunction Withdrawn Amid Governance Dispute

TIPRANKS
·
Sep 08

Hyundai Motor Securities Launches New Low-Risk Samsung-Linked Derivative Bond

TIPRANKS
·
Sep 08

The Yen's Sudden Surge is Upsetting the Carry Trade Faithful

Reuters
·
Sep 08

Martin Marietta Materials : HSBC Cuts Target Price to $665 from $750

THOMSON REUTERS
·
Sep 08

Samsung SDS Expands AI Partnerships with OpenAI and Anthropic to Accelerate Digital Transformation

Deep News
·
Sep 08

ECB Expected to Provide Open-Ended Message on Thursday

Dow Jones
·
Sep 08

China Auto Industry Body Cpca Says Tesla Exported 36,119 China-Made Vehicles in August

THOMSON REUTERS
·
Sep 08

Rubis H1 FY26 Net Income Climbs 17% to €191 Million; Revenue Rises 24% to €4.07 Billion

Reuters
·
Sep 08

Wuhan Developers Seek Transition Rules as New Housing Policies Reshape Market Dynamics

Deep News
·
Sep 08

Ascom Wins CHF 80 Million Norway Hospital Communications Framework Agreement with Helse Sør-Øst

Reuters
·
Sep 08

Solana (SOLUSD) Suddenly Goes down 1.06% on Sep 8: What You Need to Watch

TradingKey
·
Sep 08

Binance to Remove Three Stablecoin Pairs on Sept 11 in Spot Cleanup

utoday
·
Sep 08

Novartis provides update on delpacibart etedesiran (del-desiran) Phase III HARBOR study for the treatment of myotonic dystrophy type 1 (DM1)

GlobeNewswire
·
Sep 08